Search Results 511-520 of 5262 for 搜索引擎原理咨询邮箱：lgooxc@hotmail.com
Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck · Overview · Participation eligibility.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The Center for Cell Signaling in Gastroenterology at Mayo Clinic includes faculty members with expertise in biochemistry, molecular biology, endocrinology, ...
The Functional Epigenomics Laboratory is committed to creating an excellent learning environment for students and postdoctoral trainees. Graduate students. Each ...
The purpose of this FIH study to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of VVD-130037 in participants with advanced ...
Eugenia Trushina, Ph.D., and research collaborators in her Mitochondrial Neurobiology and Therapeutics Lab at Mayo Clinic have created patent-pending ...
Contact the Evidence-Based Practice Research Program at Mayo Clinic about evidence synthesis, systematic reviews, practice guidelines & training ...
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
About this study. The purpose of this study is to determine the efficacy and safety of investigational medical products (MEDI4736 monotherapy, tremelimumab ...
An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered via Transendocardial Catheter-based Injections to Subjects with Heart Failure Due to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.